Key Highlights
- Shares of Intel climbed 43% across six consecutive trading sessions, reaching a five-year peak last seen in April 2021.
- The semiconductor giant became part of Elon Musk’s Terafab initiative alongside Tesla and SpaceX, targeting 1 terawatt annually of AI and robotics computing power.
- Intel acquired Apollo Global Management’s ownership stake in its Irish manufacturing facility, triggering a 9% single-day stock gain.
- Over the trailing 12-month period, shares have climbed more than 170%, with the stock trading at a forward P/E of 117.4×.
- Analysts remain cautious, citing declining revenue trends, shrinking earnings per share, and negative free cash flow metrics.
Intel has experienced an extraordinary week that few publicly traded companies ever witness. The chip manufacturer concluded Wednesday’s session at price levels not observed since April 23, 2021, completing a six-session surge that boosted its market value by 43%. Looking back over a full year, the stock has rocketed upward by more than 170%.
However, by Thursday’s premarket trading, momentum appeared to be waning. Intel shares dipped 1.7%, influenced by broader market turbulence and questions surrounding a potential U.S.-Iran ceasefire framework.
The remarkable rally gained significant traction after Intel revealed its participation in Elon Musk’s Terafab venture — a collaborative semiconductor manufacturing effort involving Tesla and SpaceX.
“Our capabilities in designing, manufacturing, and packaging ultra-high-performance semiconductor chips at volume will support Terafab’s objective to generate 1 terawatt annually of computing capacity, driving next-generation breakthroughs in artificial intelligence and robotics,” Intel announced publicly.
Musk has described Terafab as “the most epic chip building exercise in history.” Intel’s entry into this ambitious project provided substantial upward momentum for the stock.
The second significant driver emerged last week when Intel finalized an agreement to regain complete control of its Irish chip manufacturing plant, buying out Apollo Global Management’s joint venture position. This transaction alone propelled the stock upward by 9% in a single trading day.
Financial Performance Presents Challenges
Despite the rally, not all market watchers are joining the buying spree. Several analysts are adopting a wait-and-see approach.
Intel’s top-line revenue has contracted at a 6.2% compound annual rate throughout the past five years. Earnings per share declined even more sharply at 40.1% annually during this same timeframe — a steeper deterioration than revenue, suggesting cost management hasn’t aligned with weakening demand.
Free cash flow margin contracted by 18.3 percentage points over the five-year window. During the most recent trailing twelve months, Intel’s free cash flow margin stands at negative 3%.
Valuation Concerns Emerge
Following the recent surge, Intel commands a forward price-to-earnings ratio of 117.4×. That represents a demanding valuation threshold for a corporation still navigating significant operational headwinds.
Certain analysts suggest the optimism embedded in this elevated multiple provides minimal margin for disappointment.
While Intel delivered encouraging quarterly earnings that fueled part of the recent advance, the extended-term trajectory for revenue and profitability continues to worry conservative investors.
As of Thursday morning, Intel shares were changing hands at $58.23 apiece, with premarket indicators pointing toward a slight retreat following the six-day winning streak.



